Zurich Cantonal Bank’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $186 | Hold |
103
| – | – | ﹤0.01% | 2551 |
|
|
2025
Q1 | $209 | Hold |
103
| – | – | ﹤0.01% | 2620 |
|
|
2024
Q4 | $618 | Sell |
103
-274
| -73% | -$1.64K | ﹤0.01% | 2628 |
|
|
2024
Q3 | $3.68K | Sell |
377
-34
| -8% | -$332 | ﹤0.01% | 2633 |
|
|
2024
Q2 | $8.42K | Sell |
411
-67
| -14% | -$1.37K | ﹤0.01% | 2621 |
|
|
2024
Q1 | $21.6K | Sell |
478
-15
| -3% | -$676 | ﹤0.01% | 2621 |
|
|
2023
Q4 | $23.3K | Sell |
493
-220
| -31% | -$10.4K | ﹤0.01% | 2649 |
|
|
2023
Q3 | $28.9K | Sell |
713
-54
| -7% | -$2.19K | ﹤0.01% | 2681 |
|
|
2023
Q2 | $81.7K | Buy |
767
+11
| +1% | +$1.17K | ﹤0.01% | 2432 |
|
|
2023
Q1 | $226K | Buy |
756
+57
| +8% | +$17K | ﹤0.01% | 1793 |
|
|
2022
Q4 | $240K | Buy |
699
+233
| +50% | +$80.1K | ﹤0.01% | 1721 |
|
|
2022
Q3 | $88K | Sell |
466
-25
| -5% | -$4.72K | ﹤0.01% | 2321 |
|
|
2022
Q2 | $104K | Sell |
491
-22
| -4% | -$4.66K | ﹤0.01% | 2206 |
|
|
2022
Q1 | $172K | Sell |
513
-14
| -3% | -$4.69K | ﹤0.01% | 1982 |
|
|
2021
Q4 | $171K | Buy |
527
+3
| +0.6% | +$973 | ﹤0.01% | 2177 |
|
|
2021
Q3 | $254K | Buy |
524
+194
| +59% | +$94K | ﹤0.01% | 1760 |
|
|
2021
Q2 | $153K | Buy |
330
+12
| +4% | +$5.56K | ﹤0.01% | 1991 |
|
|
2021
Q1 | $219K | Buy |
318
+203
| +177% | +$140K | ﹤0.01% | 1724 |
|
|
2020
Q4 | $85K | Hold |
115
| – | – | ﹤0.01% | 2274 |
|
|
2020
Q3 | $80K | Buy |
+115
| New | +$80K | ﹤0.01% | 2077 |
|